Risks, Innovation, Patient Care: The Week in Health

This week, planning for the 2026 FIFA World Cup has raised questions about emergency preparedness, while new partnerships aim to link science with regulation. At the same time, rising cyberattacks, the growing impact of rare diseases, and calls for better migraine care underscore the urgent need for stronger public health responses.

Ready? This is The Week in Health!

2026 World Cup Planning Highlights Health Risks

The 2026 FIFA World Cup, set to take place across North America, highlights pressing public health challenges. While tournament planning has emphasized commercial and logistical considerations, experts point to critical gaps in emergency preparedness that could strain host nations’ healthcare systems.

SECIHTI, COFEPRIS Strengthen Ties for Medical Innovation

Mexico’s Minister of Science, Humanities, Technology, and Innovation (SECIHTI) and the Federal Commission for the Protection Against Sanitary Risks (COFEPRIS) have formalized a cooperation agreement aimed at tightening the link between scientific research and health regulation.

Mexico’s Health Sector Faces Rising Cyberattacks in 1H25

Mexico’s health sector faces an unprecedented digital threat, making it a prime target for global cybercriminals. With 40.6 million cyberattack attempts recorded in the first half of 2025 across all industries, the country ranks as the second most-attacked in Latin America, putting critical infrastructure and sensitive patient data at risk.

Rare Diseases Affect 10 Million Mexicans: Health Commission

Rare diseases affect between 8 million and 10 million people in Mexico, presenting a public health challenge that requires comprehensive legal frameworks to ensure access to care, treatment and patient protection, according to Deputy Éctor Jaime Ramírez Barba, Minister of the Health Commission.

AMCEMIG Calls for Early Diagnosis, Better Migraine Care

On World Migraine Day, Sept. 12, the Mexican Association for Headaches and Migraine (AMCEMIG) calls for migraine to be recognized as a public health issue in Mexico, underscoring the need for early diagnosis, better access to innovative therapies, and improved quality of life for patients.